How to buy Kazia Therapeutics (KZA) shares
Learn how to easily invest in Kazia Therapeutics shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Kazia Therapeutics Limited is a biotechnology business based in Australia. Kazia Therapeutics shares (KZA) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Kazia Therapeutics has a trailing 12-month revenue of around $363,489. If you're looking to buy shares, check out the steps below.
How to buy shares in Kazia Therapeutics
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Kazia Therapeutics . Find the share by name or ticker symbol: KZA. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Kazia Therapeutics reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Kazia Therapeutics . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- Kazia Therapeutics key stats
- Compare share trading platforms
- Is Kazia Therapeutics stock a buy or sell?
- Kazia Therapeutics performance over time
- Kazia Therapeutics 's financials
- How volatile are Kazia Therapeutics shares?
- Does Kazia Therapeutics pay a dividend?
- Have Kazia Therapeutics shares ever split?
- Other common questions
Kazia Therapeutics stock price (ASX:KZA)Use our graph to track the performance of KZA stocks over time.
Kazia Therapeutics shares at a glance
|52-week range||$0.5 - $1.88|
|50-day moving average||$1.3065|
|200-day moving average||$1.349|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.179|
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Kazia Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Kazia Therapeutics price performance over time
|1 month (2021-07-02)||-3.79%|
|3 months (2021-05-04)||-8.63%|
|5 years (2016-07-31)||inf%|
Kazia Therapeutics financials
|Gross profit TTM||$988,000|
|Return on assets TTM||-26.94%|
|Return on equity TTM||-58.95%|
|Market capitalisation||$165.3 million|
TTM: trailing 12 months
Kazia Therapeutics share dividends
We're not expecting Kazia Therapeutics to pay a dividend over the next 12 months.
Have Kazia Therapeutics 's shares ever split?
Kazia Therapeutics 's shares were split on a 1:10 basis on 16 November 2017. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Kazia Therapeutics shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Kazia Therapeutics shares which in turn could have impacted Kazia Therapeutics 's share price.
Kazia Therapeutics share price volatility
Over the last 12 months, Kazia Therapeutics 's shares have ranged in value from as little as $0.5 up to $1.88. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Kazia Therapeutics 's is 2.7003. This would suggest that Kazia Therapeutics 's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Kazia Therapeutics overview
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is GDC-0084, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. The company is also developing Cantrixil, which is being developed for the treatment of ovarian cancer and is in hospitals across Australia and the United States under an Investigational New Drug application. It has collaboration agreements with St Jude Children's Hospital; Dana-Farber Cancer Institute; Alliance for Clinical Trials in Oncology; Memorial Sloan Kettering Cancer Centre; and the University of Newcastle. Kazia Therapeutics Limited also has collaboration with Dana-Farber Cancer Institute to investigate the use of Kazia's investigational new drug paxalisib in primary central nervous system lymphoma; Kintara Therapeutics, Inc. for the activation of paxalisib and VAL-083; and Joan & Sanford I Weill Medical College of Cornell University for Phase II clinical study using Paxalisib in combination with ketogenic diet for glioblastoma. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was founded in 1994 and is based in Sydney, Australia.
Stocks similar to Kazia Therapeutics
Kazia Therapeutics in the news
When Will Kazia Therapeutics Limited (ASX:KZA) Breakeven?
Kazia Calls for Increased Focus on Brain Cancer Research this GBM Awareness Day
Frequently asked questions
More guides on Finder
How to invest in the X2M Connect IPO
Everything we know about the X2M Connect IPO, plus information on how to buy in.
How to buy Industrial Minerals (IND.AU) shares
Steps to owning and managing Industrial Minerals shares.
How to invest in the SSH Group IPO
Everything we know about the SSH Group IPO, plus information on how to buy in.
How to invest in the Iris Metals IPO
Everything we know about the Iris Metals IPO, plus information on how to buy in.
How to invest in the Li-S Energy IPO
Everything we know about the Li-S Energy IPO, plus information on how to buy in.
How to invest in the Clarity Pharmaceuticals IPO IPO
Everything we know about the Clarity Pharmaceuticals IPO IPO, plus information on how to buy in.
How to invest in the TEK-Ocean Group IPO
Everything we know about the TEK-Ocean Group IPO, plus information on how to buy in.
How to buy HNC Coin (HNC) in Australia
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in Australia
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in Australia
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
Ask an Expert